Our transcriptomic analysis reveals significantly reduced blood expression levels of the GR itself and the two GR‐induced genes, DUSP1 and TSC22D3 in relapsing GC‐resistant as compared to relapsing GC‐sensitive patients with MS (Figure 2). The gene discussed is TSC22D3; the disease is myeloid sarcoma.